This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (57)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Seven Survival Cases

BORIS CATZ, M.D.; STEPHEN RUSSELL, M.D.

Arch Intern Med. 1961;108(3):407-417.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In the last 7 years numerous reports^1-15 have appeared in the British Medical literature dealing with myxedema, shock, and coma. A survey of these reports indicates that 19 out of 25 patients died in spite of vigorous treatment with corticosteroids, vasopressors, thyroid compounds, antibiotics, warming, and electrolyte and fluid correction. Frequently, an infectious process was present, and the syndrome of myxedemacoma was characterized in many instances by hypothermia, hypotension, cardiac failure, and low serum and chloride. Death was due to peripheric vascular failure.

In the American medical literature, we have 3 reports^16-18 of myxedema-coma. One of these patients was also in shock. There were no survivors.

The object of this study is to report 6 survival cases of myxedema with coma and shock and one survival case of myxedema in shock. We believe they are the first survival cases to be reported in the United States. This study . . . [Full Text PDF of this Article]

Author Affiliations
LOS ANGELES

Department of Medicine, University of Southern California School of Medicine, and Chief, Thyroid Clinic, Los Angeles County Hospital (Dr. Catz); Senior Resident in Medicine, College of Medical Evangelists Service, Los Angeles County Hospital (Dr. Russell).

Footnotes
Submitted for publication Aug. 10, 1960.

Read at the Fourth International Goitre Conference, London, England, July 9, 1960.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?